Interview with Sheila Kelly, Chief Executive, Proprietary Association of Great…
Thank you for having us today! You have been chief executive of the Association since 1990 and obviously observed…
Proprietary Association of Great Britain (PAGB)
Last updated: 13.02.2014
Address: PAGB, Vernon House, Sicilian Avenue, London , WC1A 2QS, United Kingdom
Tel: +44 (0)20 7242 8331
Company description
PAGB is the UK trade association for manufacturers of branded over-the-counter medicines and food supplements.
Over-the-counter is the term used for medicines that can be bought in pharmacies and in other retail outlets without a prescription. Some of the medicines can only be sold in pharmacies and pharmacists are required to supervise their sales and ask questions before supplying them to customers.
Products and services
Established in 1919, the association was founded to promote responsible consumer healthcare by controlling the advertising of all the medicines of the companies in membership through a code of advertising practice. This remains a core activity for the association although the PAGB Medicines Advertising Code now sits within a legal framework.
For more than 20 years, PAGB’s research and policy development has focused on framing self care as a level of care in the NHS and its policies.
The Department of Health publication ‘Self care – A real choice, Self care support – a practical option’ (2005) defines self care as:
‘…the actions people take for themselves, their children and their families to stay fit and maintain good physical and mental health; meet social and psychological needs; prevent illness or accidents; care for minor ailments and long-term conditions; and maintain health and wellbeing after an acute illness or discharge from hospital.’
Interviews
Related
Global / Is Everything So Wrong at GSK?
British pharmaceuticals giant, GSK, one of the UK’s largest companies by market capitalization, is once again…
Kathy Pritchard-Jones – President, International Society of Paediatric…
Kathy Pritchard-Jones, Professor of Paediatric Oncology at University College London (UCL) and President of the…
Zack Pemberton-Whiteley – CEO, Leukaemia Care
Zack Pemberton-Whiteley, CEO of UK-based blood cancer charity Leukaemia Care, discusses the importance of patient…
Europe / Vaccine Wars: What the EU/AstraZeneca Row Shows Us About Pharma Cross-Border Litigation
Stuart Evans, partner at law firm BLM and specialist in commercial disputes and litigation examines the origins and…
UK / Fastest Growing Private Pharmacos; GSK Shake-Up; Brexit Uncertainties; COVID-19 Reinfection Trial
The latest UK pharma news, including how new investment in GSK stands to reshape the country’s iconic pharma…
M&A / Jazz’s $7.2 Billion GW Pharma Deal: A Major Boost for Cannabinoid Research
The first day of March 2013 also marked a first for GW Pharmaceuticals. On that day, the British biopharmaceutical…
UK / New Post-Brexit Regulatory Alliance with Australia, Canada, Singapore & Switzerland
When the European Medicines Agency (EMA) relocated from London to Amsterdam after the UK announced its decision to…
UK-Japan FTA / Banishing UK Pharma's Brexit Blues
The signing of an agreement on the terms of a future trade relationship between Japan and the UK has been welcomed…
UK / MSD to Build USD 1.3 Billion London Research Hub in Boon for Post-Brexit Britain
US Merck (MSD globally) is following through on a 2017 commitment to invest in a new early research hub in central…
Opinion / 3 Ways the UK’s Pharma Sector is Driving Innovation
Jameel Zayed of Leyton, the UK’s leading innovation funding consultancy, highlights the British pharmaceutical…
News Roundup / UK Pharma May 2020
Below we highlight some recent developments in pharma and healthcare in the UK, including drug shortages in British…
Coronavirus / GSK & Sanofi’s Unprecedented COVID-19 Vaccine Collaboration
The world’s two leading vaccine producers, GSK of the UK and France’s Sanofi, last week announced that they are…
